ID
32084
Descripción
Study ID: 103992 Clinical Study ID: 103992 Study Title: Evaluate immunogenicity, reactogenicity & safety of 2 doses of GSK Biologicals’ oral live attenuated HRV vaccine (RIX4414 at 106.5 CCID50) when given concomitantly with OPV versus given alone (HRV vaccine dose given 15 days after the OPV dose) in healthy infants in Bangladesh Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00139334 https://clinicaltrials.gov/ct2/show/NCT00139334 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Rotavirus Vaccine Trade Name: Rotarix Study Indication: Haemophilus influenzae type b; Neisseria Meningitidis This form is only for documentation of unplanned stool samples in case of gastroenteritis epidoseds during the trial. Planned stool samples at pre-defined timepoints need to be recorded in the "planned stool sample" form for visits 3 and 5.
Link
https://clinicaltrials.gov/ct2/show/NCT00139334
Palabras clave
Versiones (1)
- 17/10/18 17/10/18 - Sarah Riepenhausen
Titular de derechos de autor
GlaxoSmithKline
Subido en
17 de octubre de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
GSK Biologicals' oral HRV vaccine given with OPV in infants NCT00139334
Gastroenteritis stools collection
- StudyEvent: ODM
Similar models
Gastroenteritis stools collection
- StudyEvent: ODM
C1550661 (UMLS CUI-2)
C1299222 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])